Profile:
Nate Amory is a partner in the Corporate Department of Latham & Watkins. Mr. Amory’s practice focuses on representing growth equity firms and private equity sponsors and their portfolio companies, in connection with:
- Acquisitions, dispositions, recapitalizations, joint ventures, and minority investments
- Reorganizations, asset and business division carve-outs, and corporate restructurings
- General corporate matters
Mr. Amory has significant experience representing founders, investors, and acquirors in public and private acquisition and sale transactions in a variety of industry sectors, including retail, technology, energy, healthcare, telecommunications systems, and infrastructure.
Experience:
Mr. Amory’s selected representative matters include representing:
- WestView Capital Partners in numerous transactions including its acquisition or disposition of or investment in:
- Wavelink
- Apex Technologies
- Abacus Group
- Alpha II
- Davex Labs
- Mintz Group
- Park Place Technologies
- Phia Group
- ABRY Partners in its acquisition and sale of NSM Insurance Group
- Spectrum Equity in numerous transactions including its acquisition or disposition of or investment in:
- Verisys
- Rain King Software
- ExactBid
- Castanea Partners in its majority investment in West Coast Fitness
- J.W. Childs in its majority investment in Honor Holdings and related acquisitions
- BV Investments in its acquisition of Precision Nutrition
- MC Partners in its investment in Neutral Connect and 5 Bars
- The acquisition by Town & Country Holdings, an H.I.G. Capital portfolio company, of Home Dynamix
- Falcon Investment Advisors in its investments in each of:
- Bobcat Disposal
- Integrity Directional Service
- Laney Directional Drilling
- Great Hill Partners in the sale of All Web Leads to Genstar
- Boathouse Capital in its investments in:
- CellTrak
- Mediafly
- OrthoFi
- Zipcar in its sale to Avis
- Network Engines in its sale to UNICOM Systems
- Micronetics in its sale to Mercury Computer Systems
- Constant Contact in its acquisition of Cardstar
- Claros Diagnostics in its sale to Opko Health
- Aratana Therapeutics in its acquisition of Vet Therapeutics
- Atrium Medical Corporation in its sale to GETINGE AB
- Boston Scientific Corporation in various joint venture, licensing supply and distribution arrangements, as well as its acquisitions of:
- Electrophysiology Division of C. R. Bard
- Rhythmia Medical
- Certain assets of Anulex Technologies
- Narragansett Brewing Company in its Series D preferred stock financing and related equity arrangements
- Numerous life sciences and technology companies in preferred stock financings and related equity arrangements